Temsirolimus is an anticancer drug that belongs to a class of medications known as mTOR inhibitors. It is used primarily in the treatment of advanced renal cell carcinoma (RCC). The drug works by blocking the mTOR pathway, which is crucial for cell growth and proliferation, thereby inhibiting the growth of cancer cells.